A matched case–control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complicationAnne Conrad, Guillaume Monneret, Lila Gilis et al.|Clinical Microbiology and Infection|2016Cited by 45
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancerPierre-Étienne Heudel, Jean-Luc Soubirou, Sylvie Chabaud et al.|ESMO Open|2021Cited by 35
HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patternsAdrien Quintela, Vanessa Escuret, Sandrine Roux et al.|Journal of Infection|2015Cited by 33
Outcome of Patients Receiving Venetoclax for Chronic Lymphocytic Leukemia (CLL) in Real-Life Clinical Practice: Results of the French ATU Program on Behalf of the Filo GroupFlorian Bouclet, Romain Guièze, Anne Calleja et al.|Blood|2018Cited by 1
Impact of Single or Associated CMV, EBV and BK Virus Reactivation Early after Allogeneic Hematopoietic Stem Cell Transplantation on Relapse IncidenceMauricette Michallet, Anne‐Sophie Michallet, Mohamad Sobh et al.|Blood|2014Cited by 0